vs
Amarin Corp plc（AMRN）与Maison Solutions Inc.（MSS）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Maison Solutions Inc.的1.6倍（$45.1M vs $27.6M），Maison Solutions Inc.净利率更高（-18.0% vs -23.3%，领先5.3%），Amarin Corp plc同比增速更快（7.0% vs -10.9%），过去两年Maison Solutions Inc.的营收复合增速更高（42.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Maison Solutions Inc.是一家专注于家居零售的企业，主要运营市场位于中国粤港澳大湾区，面向大众消费者提供高性价比的时尚家具、家居装饰用品及日常家用百货，同时布局线下实体门店与线上电商销售渠道。
AMRN vs MSS — 直观对比
营收规模更大
AMRN
是对方的1.6倍
$27.6M
营收增速更快
AMRN
高出17.9%
-10.9%
净利率更高
MSS
高出5.3%
-23.3%
两年增速更快
MSS
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $27.6M |
| 净利润 | $-10.5M | $-5.0M |
| 毛利率 | — | 23.4% |
| 营业利润率 | 35.5% | -4.9% |
| 净利率 | -23.3% | -18.0% |
| 营收同比 | 7.0% | -10.9% |
| 净利润同比 | 33.0% | -1840.5% |
| 每股收益（稀释后） | — | $-0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNMSS
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $27.6M | ||
| Q3 25 | $49.7M | $27.2M | ||
| Q2 25 | $72.7M | $34.4M | ||
| Q1 25 | $42.0M | $32.3M | ||
| Q4 24 | $62.3M | $29.4M | ||
| Q3 24 | $42.3M | $28.2M | ||
| Q2 24 | $67.5M | $16.9M |
净利润AMRNMSS
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-5.0M | ||
| Q3 25 | $-7.7M | $-1.5M | ||
| Q2 25 | $-14.1M | $-287.4K | ||
| Q1 25 | $-15.7M | $1.0M | ||
| Q4 24 | $-48.6M | $-256.0K | ||
| Q3 24 | $-25.1M | $700.9K | ||
| Q2 24 | $1.5M | $-2.8M |
毛利率AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 23.4% | ||
| Q3 25 | 44.7% | 24.1% | ||
| Q2 25 | 69.2% | 9.5% | ||
| Q1 25 | 59.8% | 21.8% | ||
| Q4 24 | -15.4% | 26.9% | ||
| Q3 24 | 38.5% | 28.9% | ||
| Q2 24 | 63.4% | 13.0% |
营业利润率AMRNMSS
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | -4.9% | ||
| Q3 25 | -22.4% | 0.7% | ||
| Q2 25 | -22.0% | -15.9% | ||
| Q1 25 | -39.9% | 3.7% | ||
| Q4 24 | -84.3% | 3.2% | ||
| Q3 24 | -59.5% | 7.3% | ||
| Q2 24 | -0.8% | -14.4% |
净利率AMRNMSS
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -18.0% | ||
| Q3 25 | -15.6% | -5.7% | ||
| Q2 25 | -19.4% | -0.8% | ||
| Q1 25 | -37.4% | 3.1% | ||
| Q4 24 | -78.0% | -0.9% | ||
| Q3 24 | -59.4% | 2.5% | ||
| Q2 24 | 2.3% | -16.4% |
每股收益（稀释后）AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $-0.23 | ||
| Q3 25 | $-0.02 | $-0.08 | ||
| Q2 25 | $-0.03 | $-0.02 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.12 | $-0.01 | ||
| Q3 24 | $-0.06 | $0.04 | ||
| Q2 24 | $0.00 | $-0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | — |
| 总债务越低越好 | — | $2.6M |
| 股东权益账面价值 | — | $11.6M |
| 总资产 | $645.8M | $75.4M |
| 负债/权益比越低杠杆越低 | — | 0.22× |
8季度趋势，按日历期对齐
现金及短期投资AMRNMSS
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | — | ||
| Q3 25 | $286.6M | $1.1M | ||
| Q2 25 | $298.7M | $775.4K | ||
| Q1 25 | $281.8M | $445.4K | ||
| Q4 24 | $294.2M | $355.7K | ||
| Q3 24 | $305.7M | $588.9K | ||
| Q2 24 | $306.7M | $2.1M |
总债务AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M |
股东权益AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $11.6M | ||
| Q3 25 | $458.9M | $10.1M | ||
| Q2 25 | $464.9M | $11.7M | ||
| Q1 25 | $473.7M | $12.0M | ||
| Q4 24 | $486.2M | $10.9M | ||
| Q3 24 | $531.4M | $11.2M | ||
| Q2 24 | $551.9M | $10.5M |
总资产AMRNMSS
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $75.4M | ||
| Q3 25 | $659.8M | $73.3M | ||
| Q2 25 | $670.1M | $77.4M | ||
| Q1 25 | $655.7M | $82.7M | ||
| Q4 24 | $685.3M | $82.7M | ||
| Q3 24 | $750.6M | $82.1M | ||
| Q2 24 | $799.9M | $82.4M |
负债/权益比AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-1.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $-1.7M | ||
| Q3 25 | $-12.7M | $1.1M | ||
| Q2 25 | $16.6M | $-1.6M | ||
| Q1 25 | $-12.5M | $1.7M | ||
| Q4 24 | $-13.3M | $1.1M | ||
| Q3 24 | $-2.4M | $3.6M | ||
| Q2 24 | $-2.7M | $-2.6M |
现金转化率AMRNMSS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
